D
Ocular Therapeutix, Inc. OCUL
$11.87 -$0.43-3.50% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -216.75M -192.71M -193.51M -174.34M -138.36M
Total Depreciation and Amortization 3.92M 3.85M 3.79M 3.79M 3.72M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 31.20M 35.10M 65.27M 70.48M 55.97M
Change in Net Operating Assets 5.73M 8.31M -10.23M -17.64M -10.21M
Cash from Operations -175.90M -145.46M -134.68M -117.70M -88.88M
Capital Expenditure -3.47M -2.97M -1.29M -1.55M -1.72M
Sale of Property, Plant, and Equipment 130.00K -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -3.34M -2.97M -1.29M -1.55M -1.72M
Total Debt Issued -- -- -- 0.00 82.47M
Total Debt Repaid -- -- -- 0.00 -26.13M
Issuance of Common Stock 110.68M 15.07M 332.11M 435.77M 432.36M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- 0.00 -5.18M
Cash from Financing 110.68M 15.07M 332.11M 435.77M 483.52M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -68.56M -133.36M 196.15M 316.52M 392.93M